Recent News Releases

Mar 24, 2020
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Mar 20, 2020
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Feb 14, 2020
InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and...

See All News Releases

Latest Presentation

Unlocking the Potential of Cannabinoid Medicines

March 2020

Download pdf

Letter to Shareholders

Annual Letter to Shareholders 2020

January 17, 2020

Download pdf

Company Fact Sheet

Company Fact Sheet

September, 2019

Download pdf

SEDAR® Filings
Loading data...
Financial Reports

Quarterly and Annual Financial Results

2020

Second quarter, 2020 (quarter ended December 31, 2019)
First quarter, 2020 (quarter ended September 30, 2019)

2019

AGM Documents
Fourth quarter, 2019 (full year ended June 30, 2019)
Third quarter, 2019 (quarter ended March 31, 2019)
Second quarter, 2019 (quarter ended December 31, 2018)
First quarter, 2019 (quarter ended September 30, 2018)

2018

AGM Documents
Fourth quarter, 2018 (full year ended June 30, 2018)
Third quarter, 2018 (quarter ended March 31, 2018)
Second quarter, 2018 (quarter ended December 31, 2017)
First quarter, 2018 (quarter ended September 30, 2017)

2017

Fourth quarter, 2017 (full year ended June 30, 2017)
Third quarter, 2017 (quarter ended March 31, 2017)
Second quarter, 2017 (quarter ended December 31, 2016)
First quarter, 2017 (quarter ended September 30, 2016)

Stock Performance

OTCQX: IMLFFTSX: IN
-
Loading...
Display Events
 
 
 
 
Chart Style
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings Events data provided by Wall Street Horizon.
OTCQX: IMLFFTSX: IN
Analyst Coverage
Firm Analyst E-mail Phone
Edison Investment Research Max Jacobs MJacobs@edisongroup.com +1 (646) 653-7027
Maxim Group, LLC Jason McCarthy, Ph.D. jmccarthy@maximgrp.com +1 (212) 895-3556
ROTH Capital Partners Scott R. Henry, CFA shenry@roth.com +1 (406) 425-0563